Imprivata Enterprise Access Management for EPCS (formerly Imprivata Confirm ID for EPCS) is the fast, secure signing solution for Electronic Prescribing of Controlled Substances (EPCS). It is the most comprehensive platform for provider identity proofing, supervised enrollment of credentials, two-factor authentication, and reporting, helping healthcare organizations meet federal and state-level requirements for EPCS.
To protect against diversion and fraud, the DEA requires two-factor authentication for EPCS. But adding extra steps to prescribing workflows can often hinder clinical adoption. That’s why Imprivata offers the most comprehensive range of two-factor authentication options, making EPCS workflows fast and convenient.
The DEA requires all practitioners who will be prescribing controlled substances electronically to undergo identity proofing, even if they have already been authorized to prescribe controlled substances using paper. This whitepaper outlines both individual and institutional identity proofing as well as the logical access control requirements necessary for a successful EPCS initiative.